003060.KO Aprogen Pharmaceuticals Inc

Healthcare Pharmaceuticals Korea Stock Exchange
1,313 KRW
Close of Nov 5, 2026
1,270 9,945
Market cap
KRW 21.4B
P/E
-
P/B
0.11x
ROE
-18.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 003060.KO undervalued?

Graham number

The Graham number of Aprogen Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aprogen Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Aprogen Pharmaceuticals Inc yet.

Aprogen Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aprogen Pharmaceuticals Inc

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea.

Full company profile